Naomi Y Ko (Naomi Ko)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 16

Top Topics

Health Insurance

Editorial Comment

Epidermal Growth Factor Receptor

Top Venues

JCO oncology practice

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Erica L Mayer, Yue Ren, Nikhil Wagle, Reshma L Mahtani, Cynthia X Ma, Angela M DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy D Miller, Yara G Abdou, Elizabeth C Riley, Rubina Qamar, Priyanka Sharma, Sonya A Reid, Natalie Sinclair, Meredith Faggen, Caroline C Block, Naomi Y Ko, Ann H Partridge, Wendy Y Chen, Michelle DeMeo, Victoria Attaya, Amanda Okpoebo, Jillian Alberti, Yuan Liu, Eric Gauthier, Harold J Burstein, Meredith M Regan, Sara M Tolaney
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Erica L Mayer, Yue Ren, Nikhil Wagle, Reshma L Mahtani, Cynthia X Ma, Angela M DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy D Miller, Yara G Abdou, Elizabeth C Riley, Rubina Qamar, Priyanka Sharma, Sonya A Reid, Natalie Sinclair, Meredith Faggen, Caroline C Block, Naomi Y Ko, Ann H Partridge, Wendy Y Chen, Michelle DeMeo, Victoria Attaya, Amanda Okpoebo, Jillian Alberti, Yuan Liu, Eric Gauthier, Harold J Burstein, Meredith M Regan, Sara M Tolaney
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Erica L Mayer, Yue Ren, Nikhil Wagle, Reshma L Mahtani, Cynthia X Ma, Angela M DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy D Miller, Yara G Abdou, Elizabeth C Riley, Rubina Qamar, Priyanka Sharma, Sonya A Reid, Natalie Sinclair, Meredith Faggen, Caroline C Block, Naomi Y Ko, Ann H Partridge, Wendy Y Chen, Michelle DeMeo, Victoria Attaya, Amanda Okpoebo, Jillian Alberti, Yuan Liu, Eric Gauthier, Harold J Burstein, Meredith M Regan, Sara M Tolaney
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Naomi Y Ko, Tsion G Fikre, Anne K Buck, Emily Restrepo, Erica T Warner
Breast cancer survivorship experiences among Black women. Cancer 129 (S19) (2023)
Jihoon J Choi, Tsion Fikre, Alexandra Fischman, Anne K Buck, Naomi Y Ko
The Role of Race and Insurance Status in Access to Genetic Counseling and Testing Among High-Risk Breast Cancer Patients. The oncologist 27 (10) (2022)
Claire E P Smith, Paul K Marcom, Zahi Mitri, Naomi Y Ko
Predictors of long-term durable response in de novo HER2-positive metastatic breast cancer and the real-world treatment experience at two institutions. Breast cancer research and treatment 196 (1) (2022)
Jasmine V Patel, David M Hughes, Naomi Y Ko
OPTIMAL Breast Cancer Care: Effect of an Outpatient Pharmacy Team to Improve Management and Adherence to Oral Cancer Treatment. JCO oncology practice (2022)
Tracy A Battaglia, Christine M Gunn, Sharon M Bak, JoHanna Flacks, Kerrie P Nelson, Na Wang, Naomi Y Ko, Samantha J Morton
Patient navigation to address sociolegal barriers for patients with cancer: A comparative-effectiveness study. Cancer (2022)
Jifang Zhou, Karen I Sweiss, Edith A Nutescu, Jin Han, Pritesh R Patel, Naomi Y Ko, Todd A Lee, Brian C-H Chiu, Gregory Sampang Calip
Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare. JCO oncology practice 17 (3) (2021)
Frank L Lombardi, Naser Jafari, Kimberly A Bertrand, Lauren J Oshry, Michael R Cassidy, Naomi Y Ko, Gerald V Denis
Novel semi-automated algorithm for high-throughput quantification of adipocyte size in breast adipose tissue, with applications for breast cancer microenvironment. Adipocyte 9 (1) (2021)
Kate Festa, Ariel E Hirsch, Michael R Cassidy, Lauren Oshry, Kathryn Quinn, Margaret M Sullivan, Naomi Y Ko
Breast Cancer Treatment Delays at an Urban Safety Net Hospital Among Women Experiencing Homelessness. Journal of community health 45 (3) (2021)
Nita H Mukand, Ashwini Zolekar, Naomi Y Ko, Gregory S Calip
Risks of Second Primary Gynecologic Cancers following Ovarian Cancer Treatment in Asian Ethnic Subgroups in the United States, 2000-2016. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29 (11) (2020)
Naomi Y Ko, Muhammad M Qureshi, Oluwadamilola T Oladeru, Michael R Cassidy, Lauren Oshry, Minh-Tam Truong, Ariel E Hirsch
Racial differences in genomic testing and receipt of endocrine therapy in early-stage breast cancer. Breast cancer research and treatment 184 (3) (2020)
Vishal K Gupta, Michael J Dennis, Emily Mann, Joseph O Jacobson, Naomi Y Ko
Identifying Actionable Causes of Potentially Avoidable Readmissions to an Oncology Service at a Safety Net Hospital. JCO oncology practice 17 (3) (2020)
Saptaparni Ghosh, Minghua L Chen, Janice Weinberg, Tsion Fikre, Naomi Y Ko
Hepatitis C Virus Infection and Chemotherapy in Breast Cancer: A Retrospective Chart Analysis. The oncologist 25 (10) (2020)
Ashley Tran, Shayna Sarosiek, Naomi Y Ko
Challenges in the use of immunotherapy in metastatic melanoma. BMJ case reports 2016 (2016)